Login / Signup

Longitudinal immune cell monitoring identified CD14++ CD16+ intermediate monocyte as a marker of relapse in patients with ANCA-associated vasculitis.

Kotaro MatsumotoKatsuya SuzukiKeiko YoshimotoNoriyasu SekiHideto TsujimotoKenji ChibaTsutomu Takeuchi
Published in: Arthritis research & therapy (2020)
Chronological changes in CD14++ CD16+ intermediate monocyte counts can be a marker of disease relapse in AAV patients.
Keyphrases
  • end stage renal disease
  • dendritic cells
  • peripheral blood
  • newly diagnosed
  • chronic kidney disease
  • ejection fraction
  • endothelial cells
  • peritoneal dialysis
  • cross sectional
  • patient reported outcomes
  • gene therapy